Effects of melanin upon susceptibility of Cryptococcus to antifungals

Microbiology and Immunology

Volumn 47, Issue 4, 2003, Pages 271-277

  Ikeda, Reiko ^a   Sugita, Takashi ^a   Jacobson, Eric S ^b,c   Shinoda, Takako ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cryptococcus albidus; Cryptococcus neoformans; Melanin; Susceptibility

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUORESCENT DYE; LEVODOPA; MELANIN;

ARTICLE; CELL ADHESION; CELL SURVIVAL; CELL WALL; CONTROLLED STUDY; CRYPTOCOCCUS; CRYPTOCOCCUS ALBIDUS; CRYPTOCOCCUS NEOFORMANS; DRUG SENSITIVITY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; FUNGAL CELL; FUNGUS GROWTH; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; VIRULENCE;

CRYPTOCOCCUS ALBIDUS; FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 0037270150     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2003.tb03395.x     Document Type: Article

References (28)

1. Butler, M.J., and Day, A.W. 1998. Fungal melanins: a review. Can. J. Microbiol. 44: 1115-1136.
2. Casadevall, A., and Perfect, J.R. 1998. Virulence factors, p. 145-176. In Casadevall, A., and Perfect, J.R. (eds), Cryptococcus neoformans, ASM Press, Washington, D.C.
3. Casadevall, A., Rosas, A.L., and Nosanchuk, J.D. 2000. Melanin and virulence in Cryptococcus neoformans. Curr. Opin. Microbiol. 3: 354-358.
4. Doering, T.L., Nosanchuk, J.D., Roberts, W.K., and Casadevall, A. 1999. Melanin as a potential cryptococcal defence against microbicidal proteins. Med. Mycol. 37: 175-181.
5. Elgart, G.W. 1996. Chromoblastomycosis. Dermatol. Clin. 14: 77-83.
6. Hamilton, A.J., and Gomez, B.L. 2002. Melanins in fungal pathogens. J. Med. Microbiol. 51: 189-191.
7. Ikeda, R., Sugita, T., Jacobson, E.S., and Shinoda, T. 2002. Laccase and melanization in clinically important Cryptococcus species other than Cryptococcus neoformans. J. Clin. Microbiol. 40: 1214-1218.
8. Jacobson, E.S. 2000. Pathogenic roles for fungal melanins. Clin. Microbiol. Rev. 13: 708-717.
9. Johnson, L.B., Bradley, S.F., and Kauffman, C.A. 1998. Fungaemia due to Cryptococcus laurentii and a review of non-neoformans cryptococcaemia. Mycoses 41: 277-280.
10. Klepser, M.E., Ernst, E.J., Lewis, R.E., Ernst, M.E., and Pfaller, M.A. 1998. Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods. Antimicrob. Agents Chemother. 42: 1207-1212.
11. Kordossis, T, Avlami, A., Velegraki, A., Stefanou, I., Georgakopoulos, G., Papalambrou, C., and Legakis, N.J. 1998. First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients. Med. Mycol. 36: 335-339.
12. Kunova, A., and Krcmery, V. 1999. Fungaemia due to thermophilic cryptococci: 3 cases of Cryptococcus laurentii bloodstream infections in cancer patients receiving antifungals. Scand. J. Infect. Dis. 31: 328.
13. Kwon-Chung, K.J., Polacheck, I., and Popkin, T.J. 1982. Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J. Bacteriol. 150: 1414-1421.
14. Liu, L., Tewari, R.P., and Williamson, P.R. 1999. Laccase protects C. neoformans from antifungal activity of alveolar macrophages. Infect. Immun. 67: 6034-6039.
15. Loison, J., Bouchara, J.P., Guého, E., de Gentile, L., Cimon, B., Chennebault, J.M., and Chabasse, D. 1996. First report of Cryptococcus albidus septicaemia in an HIV patient. J. Infect. 33: 139-140.
16. National Committee for Clinical Laboratory Standards, 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
17. Rhodes, J.C., Polacheck, I., and Kwon-Chung, K.J. 1982. Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans. Infect. Immun. 36: 1175-1184.
18. Rosas, A.L., and Casadevall, A. 1997. Melanization affects susceptibility of Cryptococcus neoformans to heat and cold. FEMS Microbiol. Lett. 153: 265-272.
19. Rosas, A.L., and Casadevall, A. 2001. Melanization decreases the susceptibility of Cryptococcus neoformans to enzymatic degradation. Mycopathologia 151: 53-56.
20. Salas, S.D., Bennett, J.E., Kwon-Chung, K.J., Perfect, J.R., and Williamson, P.R. 1996. Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans. J. Exp. Med. 184: 377-386.
21. Sugita, T., Takashima, M., Ikeda, R., Nakase, T., and Shinoda, T. 2001. Intraspecies diversity of Cryptococcus albidus isolated from human as revealed by sequences of internal transcribed spacer regions. Microbiol. Immunol. 45: 291-297.
22. van Duin, D., Casadevall, A., and Nosanchuk, J.D. 2002. Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin. Antimicrob. Agents Chemother. 46: 3394-3400.
23. Wang, Y., and Casadevall, A. 1994. Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants. Infect. Immun. 62: 3004-3007.
24. Wang, Y., and Casadevall, A. 1994. Decreased susceptibility of melanized Cryptococcus neoformans to UV light. Appl. Environ, Microbiol. 60: 3864-3866.
25. Wang, Y., and Casadevall, A. 1994, Growth of Cryptococcus neoformans in presence of L-dopa decreases its susceptibility to amphotericin B. Antimicrob. Agents Chemother. 38: 2648-2650.
26. Wang, Y., Aise, P., and Casadevall, A. 1996, Melanin, melanin "ghosts," and melanin composition in Cryptococcus neoformans. Infect. Immun. 64: 2420-2424.
27. Williamson, P.R., Wakamatsu, K., and Ito, S. 1998. Melanin biosynthesis in Cryptococcus neoformans. J. Bacteriol. 180: 1570-1572.
28. Williamson, P.R. 1994. Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase. J. Bacteriol. 176: 656-664.